Drug Target Identification Services | PharmaCompare.com

Companies that sell Drug Target Identification / Pharmaceutical Hit Identification Services

AMRI

Dalton Pharma Services

Toronto, ON, Canada

Dalton Pharma Services

Toronto, ON, Canada

MilliporeSigma

SCYNEXIS, Inc.

Research Triangle Park, NC, United States

SCYNEXIS, Inc.

Jersey City, NJ, United States

VectorB2B

Lisbon, Portugal

Tags:

Please Login or Register to Create Tags

Articles

Industry News: Q4 Pharmaceutical Outsourcing
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer
Malvern exhibits recently acquired MicroCal and NanoSight brands alongside new Mastersizer and Zetasizer products at AAPS 2014
Societal CDMO to Support Clinical Development of Multiple Novel Therapeutics
Felicitex Therapeutics and Selvita Initiate Strategic Collaboration to Target Cancer Quiescence
ZoBio and Domainex Join Forces to Deliver Crucial Drug Target Information to support FORMA Therapeutics’ Drug Discovery Programs
Aldena Therapeutics Selects PCI Pharma Services to Manufacture Dermatological Disease Treatments
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings For Monoclonal Antibodies
A Quarterly Review of New Drug Applications April - June 2022
Oxeltis and Molecular Forecaster Collaborate to Enhance Drug Design and Synthesis
CN Bio Expands Service Offering to Support Oncology Drug Discovery
Sygnature Discovery Successfully Identifies Potent SHP2 Degrader Compounds
Cresset Increases Its North America Presence with New Boston Site
Biopharma Execs are Turning to New Science to Develop New Treatments
The Power of Collaboration: Using the Pandemic’s United Effort to Serve as a Model for Future Drug Development
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Caris Life Sciences Partner with Merck to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Optibrium Publishes Major Peer-Reviewed Study on AI Applications to Global Pharma Data
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
USP Launches R&D Analytical Solutions to Advance Continuous Manufacturing Technologies
LifeNet Health LifeSciences Launches New Assay Service for Drug Discovery
Ubiquigent Extends and Expands Drug Discovery Collaboration with Bristol Myers Squibb
Rho Awarded NIH-NIAID Contract to Support Clinical Research in Autoimmune Diseases
SRI and Sanofi Collaborate On AI Drug Discovery
Samsung Biologics Unlocks Additional Capacity for Production at its Newest Plant
Catalent to Expand Its Biologics Analytical Services with New Facility in Durham, NC
Pelican Names Mike Davis as CEO of Peli BioThermal
Vaccizone Picks Exothera to Develop and Manufacture SARS-CoV-2 Vaccine
Charles River Labs Receives EMA Approval to Produce Allogeneic Cell Therapy Products
Metrion Biosciences Appoints New Chief Commercial Officer and Head of Global Business Development
Discovery Life Sciences Acquires In Vitro ADMET Laboratories
Charles River and Aitia Form Strategic Alliance to Harness Logica in Discovery Programs Targeting Neurodegenerative Diseases and Oncology
Optibrium Appoints Steve Yemm as Chief Commercial Officer
The Role of Artificial Intelligence in Drug Discovery
Cambrex Completes Acquisition of Snapdragon Chemistry
Outsourcing Facilities Association’s Settlement Will Expedite FDA Review of Bulk Drug Ingredients

2025 Contract Services Directory and Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary print or
digital subscription

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.